Your browser doesn't support javascript.
loading
A Large-Scale Analysis of Genetic Variants within Putative miRNA Binding Sites in Prostate Cancer.
Stegeman, Shane; Amankwah, Ernest; Klein, Kerenaftali; O'Mara, Tracy A; Kim, Donghwa; Lin, Hui-Yi; Permuth-Wey, Jennifer; Sellers, Thomas A; Srinivasan, Srilakshmi; Eeles, Rosalind; Easton, Doug; Kote-Jarai, Zsofia; Amin Al Olama, Ali; Benlloch, Sara; Muir, Kenneth; Giles, Graham G; Wiklund, Fredrik; Gronberg, Henrik; Haiman, Christopher A; Schleutker, Johanna; Nordestgaard, Børge G; Travis, Ruth C; Neal, David; Pharoah, Paul; Khaw, Kay-Tee; Stanford, Janet L; Blot, William J; Thibodeau, Stephen; Maier, Christiane; Kibel, Adam S; Cybulski, Cezary; Cannon-Albright, Lisa; Brenner, Hermann; Kaneva, Radka; Teixeira, Manuel R; Spurdle, Amanda B; Clements, Judith A; Park, Jong Y; Batra, Jyotsna.
Affiliation
  • Stegeman S; Australian Prostate Cancer Research Centre-Qld, Institute of Health and Biomedical Innovation and School of Biomedical Sciences, Translational Research Institute, Queensland University of Technology, Brisbane, Australia.
  • Amankwah E; Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, Florida.
  • Klein K; Statistics Unit, QIMR Berghofer Medical Research Institute, Brisbane, Australia.
  • O'Mara TA; Molecular Cancer Epidemiology Laboratory, Genetics and Computational Biology Division, QIMR Berghofer Medical Research Institute, Brisbane, Australia.
  • Kim D; Department of Molecular Oncology, Moffitt Cancer Center, Tampa, Florida.
  • Lin HY; Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, Florida.
  • Permuth-Wey J; Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, Florida.
  • Sellers TA; Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, Florida.
  • Srinivasan S; Australian Prostate Cancer Research Centre-Qld, Institute of Health and Biomedical Innovation and School of Biomedical Sciences, Translational Research Institute, Queensland University of Technology, Brisbane, Australia.
  • Eeles R; The Institute of Cancer Research, London, United Kingdom. Royal Marsden NHS Foundation Trust, Fulham and Sutton, London and Surrey, United Kingdom.
  • Easton D; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Laboratory, Cambridge, United Kingdom.
  • Kote-Jarai Z; The Institute of Cancer Research, London, United Kingdom.
  • Amin Al Olama A; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Laboratory, Cambridge, United Kingdom.
  • Benlloch S; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Laboratory, Cambridge, United Kingdom.
  • Muir K; University of Warwick, Coventry, United Kingdom.
  • Giles GG; Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Victoria, Australia. Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Victoria, Australia.
  • Wiklund F; Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden.
  • Gronberg H; Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden.
  • Haiman CA; Department of Preventive Medicine, Keck School of Medicine, University of Southern California/Norris Comprehensive Cancer Center, Los Angeles, California.
  • Schleutker J; Department of Medical Biochemistry and Genetics, University of Turku, Turku, Finland. Institute of Biomedical Technology/BioMediTech, University of Tampere and FimLab Laboratories, Tampere, Finland.
  • Nordestgaard BG; Department of Clinical Biochemistry, Herlev Hospital, Copenhagen University Hospital, Herlev, Denmark.
  • Travis RC; Cancer Epidemiology Unit, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom.
  • Neal D; Surgical Oncology (Uro-Oncology: S4), University of Cambridge, Addenbrooke's Hospital, Cambridge; Cancer Research UK, Cambridge Research Institute, Cambridge, United Kingdom.
  • Pharoah P; Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Strangeways Laboratory, Cambridge, United Kingdom.
  • Khaw KT; Cambridge Institute of Public Health, University of Cambridge, Cambridge, United Kingdom.
  • Stanford JL; Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington. Department of Epidemiology, School of Public Health, University of Washington, Seattle, Washington.
  • Blot WJ; International Epidemiology Institute, Rockville, Maryland.
  • Thibodeau S; Mayo Clinic, Rochester, Minnesota.
  • Maier C; Department of Urology, University Hospital Ulm, Ulm, Germany. Institute of Human Genetics, University Hospital Ulm, Ulm, Germany.
  • Kibel AS; Brigham and Women's Hospital/Dana-Farber Cancer Institute, Boston, Massachusetts. Washington University, St. Louis, Missouri.
  • Cybulski C; International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
  • Cannon-Albright L; Division of Genetic Epidemiology, Department of Medicine, University of Utah School of Medicine, Salt Lake City, Utah.
  • Brenner H; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center, Heidelberg, Germany. German Cancer Consortium (DKTK), Heidelberg, Germany.
  • Kaneva R; Molecular Medicine Center and Department of Medical Chemistry and Biochemistry, Medical University-Sofia, Sofia, Bulgaria.
  • Teixeira MR; Department of Genetics, Portuguese Oncology Institute, Porto; Biomedical Sciences Institute (ICBAS), Porto University, Porto, Portugal.
  • Spurdle AB; Molecular Cancer Epidemiology Laboratory, Genetics and Computational Biology Division, QIMR Berghofer Medical Research Institute, Brisbane, Australia.
  • Clements JA; Australian Prostate Cancer Research Centre-Qld, Institute of Health and Biomedical Innovation and School of Biomedical Sciences, Translational Research Institute, Queensland University of Technology, Brisbane, Australia.
  • Park JY; Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, Florida.
  • Batra J; Australian Prostate Cancer Research Centre-Qld, Institute of Health and Biomedical Innovation and School of Biomedical Sciences, Translational Research Institute, Queensland University of Technology, Brisbane, Australia. jyotsna.batra@qut.edu.au.
Cancer Discov ; 5(4): 368-79, 2015 Apr.
Article in En | MEDLINE | ID: mdl-25691096
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Genetic Variation / Binding Sites / RNA, Messenger / MicroRNAs Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Humans / Male / Middle aged Language: En Journal: Cancer Discov Year: 2015 Document type: Article Affiliation country: Australia Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Genetic Variation / Binding Sites / RNA, Messenger / MicroRNAs Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Humans / Male / Middle aged Language: En Journal: Cancer Discov Year: 2015 Document type: Article Affiliation country: Australia Country of publication: United States